Results 161 to 169 of about 3,260 (169)

Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopenia

Annals of Hematology, 2015
, Jeffrey Wasser, Yoshiaki Tomiyama
exaly  

Immune globulin/Thrombopoietin/Thrombopoietin receptor agonists

Reactions Weekly
openaire   +1 more source

Diverse functions of the thrombopoietin receptor agonist romiplostim rescue individuals exposed to lethal radiation

Free Radical Biology and Medicine, 2019
Ikuo Kashiwakura
exaly  

Effects of Food and Calcium Carbonate on the Pharmacokinetics of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist

Clinical Therapeutics, 2019
Takayuki Katsube, Toshihiro Wajima
exaly  

PREPARATION PROCESS OF AN AGONIST OF THE THROMBOPOIETIN RECEPTOR

2014
BARTRA SANMARTI MARTÍ, SOLSONA ROCABERT JOAN GABRIEL, CRUCES COLADO JACOBO, ENJO BABIO JUAN, PAMPIN CASAL MARÍA BEGOÑA   +4 more
openaire   +2 more sources

[Development of thrombopoietin receptor agonists].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2010
openaire   +1 more source

Use of Peptide Thrombopoietin Receptor Agonist Romiplostim (Nplate) in a Case of Primary HIV-Associated Thrombocytopenia

Journal of the International Association of Providers of AIDS Care, 2014
exaly  

Thrombopoietin receptor agonist-related thromboembolism

Reactions Weekly
openaire   +1 more source

Agonist antibody to human thrombopoietin receptor

2011
KAI MASAYUKI, MOTOKI KAZUHIRO, KATAOKA SHIRO, YOSHIDA HIDEAKI, HAGIWARA TETSUYA   +4 more
openaire   +3 more sources